688520 神州细胞
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-13.30294.728224.112-475.870-227.230
总资产报酬率 ROA (%)2.676-14.521-25.261-57.092-57.653
投入资产回报率 ROIC (%)3.359-18.787-35.586-85.652-58.440

边际利润分析
销售毛利率 (%)96.65597.11096.68994.76181.944
营业利润率 (%)32.8500.337-34.958-637.576-217,561.313
息税前利润/营业总收入 (%)17.155-15.291-42.225-624.971-213,149.714
净利润/营业总收入 (%)12.148-21.026-50.827-646.514-217,591.211

收益指标分析
经营活动净收益/利润总额(%)212.8425.63675.009102.089107.663
价值变动净收益/利润总额(%)0.026-0.624-1.174-1.125-1.389
营业外收支净额/利润总额(%)-170.410101.60431.2231.3830.014

偿债能力分析
流动比率 (X)0.5740.5231.1160.8852.319
速动比率 (X)0.4650.4230.9760.7502.229
资产负债率 (%)118.469122.285108.852116.82264.631
带息债务/全部投入资本 (%)110.765114.83269.03598.459--
股东权益/带息债务 (%)-20.553-24.270-16.601-27.002177.157
股东权益/负债合计 (%)-15.406-18.032-7.946-14.12054.953
利息保障倍数 (X)3.426-2.667-4.908-29.010-47.991

营运能力分析
应收账款周转天数 (天)55.46760.37460.424218.5680.000
存货周转天数 (天)916.1511,302.1971,496.6883,297.9200.000